RWM
AMRX icon

Ritholtz Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Ritholtz Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
101,808
-749
-0.7% -$10.3K 0.03% 456
2026
Q1 		$1.27M Sell
102,557
-165
-0.2% -$2.21K 0.02% 492
2025
Q4 		$1.29M Sell
102,722
-699
-0.7% -$8K 0.02% 446
2025
Q3 		$1.04M Sell
103,421
-1,319
-1% -$11.8K 0.02% 489
2025
Q2 		$847K Sell
104,740
-15,080
-13% -$114K 0.02% 495
2025
Q1 		$1M Sell
119,820
-2,653
-2% -$22.1K 0.03% 402
2024
Q4 		$970K Sell
122,473
-13,078
-10% -$110K 0.03% 366
2024
Q3 		$1.13M Sell
135,551
-24,159
-15% -$189K 0.03% 347
2024
Q2 		$1.01M Buy
159,710
+25,869
+19% +$164K 0.03% 347
2024
Q1 		$811K Buy
133,841
+19,616
+17% +$111K 0.03% 407
2023
Q4 		$693K Buy
114,225
+32,937
+41% +$147K 0.03% 412
2023
Q3 		$343K Buy
+81,288
New +$303K 0.02% 530

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Ritholtz Wealth Management's AMRX Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Amneal Pharmaceuticals (AMRX) stake by 0.73% in Q2 2026, selling an estimated $10.3K and leaving 101,808 shares worth $1.76M. The position accounts for 0.03% of the portfolio, ranked #456.

Ritholtz Wealth Management first reported a position in AMRX in Q3 2023 and has held it in 12 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Ritholtz Wealth Management held 101,808 shares of Amneal Pharmaceuticals worth $1.76M as of Q2 2026.
  • Ritholtz Wealth Management sold 749 Amneal Pharmaceuticals shares in Q2 2026, an estimated $10.3K.
  • Amneal Pharmaceuticals made up 0.03% of Ritholtz Wealth Management's portfolio in Q2 2026, its #456 holding.
  • Ritholtz Wealth Management first reported a position in Amneal Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.